应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DYN 戴纳基
已收盘 04-21 16:00:00 EDT
9.33
+1.16
+14.20%
盘后
9.33
+0.00
0.00%
19:43 EDT
最高
9.79
最低
8.01
成交量
450.60万
今开
8.17
昨收
8.17
日振幅
21.79%
总市值
10.55亿
流通市值
9.08亿
总股本
1.13亿
成交额
4,160万
换手率
4.63%
流通股本
9,728万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
戴纳基盘中异动 早盘股价大跌5.10%
市场透视 · 04-16
戴纳基盘中异动 早盘股价大跌5.10%
戴纳基盘中异动 早盘急速下跌5.24%
市场透视 · 03-10
戴纳基盘中异动 早盘急速下跌5.24%
戴纳基2024财年实现净利润-3.17亿美元,同比减少34.32%
市场透视 · 03-07
戴纳基2024财年实现净利润-3.17亿美元,同比减少34.32%
戴纳基盘中异动 早盘股价大跌5.03%
市场透视 · 03-04
戴纳基盘中异动 早盘股价大跌5.03%
戴纳基盘中异动 股价大跌5.15%
市场透视 · 02-27
戴纳基盘中异动 股价大跌5.15%
Dyne Therapeutics 2024年第四季度每股收益 $(0.88),优于预期$(0.99)
财报速递 · 02-27
Dyne Therapeutics 2024年第四季度每股收益 $(0.88),优于预期$(0.99)
戴纳基盘中异动 股价大跌5.32%
市场透视 · 02-11
戴纳基盘中异动 股价大跌5.32%
戴纳基盘中异动 大幅下跌5.07%报14.59美元
市场透视 · 02-10
戴纳基盘中异动 大幅下跌5.07%报14.59美元
戴纳基盘中异动 快速拉升5.17%报16.49美元
市场透视 · 02-06
戴纳基盘中异动 快速拉升5.17%报16.49美元
戴纳基盘中异动 股价大涨5.07%报15.54美元
市场透视 · 02-05
戴纳基盘中异动 股价大涨5.07%报15.54美元
戴纳基盘中异动 大幅上涨5.19%报14.59美元
市场透视 · 02-04
戴纳基盘中异动 大幅上涨5.19%报14.59美元
戴纳基盘中异动 早盘大幅下挫5.03%
市场透视 · 02-03
戴纳基盘中异动 早盘大幅下挫5.03%
戴纳基盘中异动 早盘股价大涨5.09%
市场透视 · 01-31
戴纳基盘中异动 早盘股价大涨5.09%
戴纳基盘中异动 股价大涨5.45%
市场透视 · 01-30
戴纳基盘中异动 股价大涨5.45%
戴纳基盘中异动 快速上涨5.19%报14.40美元
市场透视 · 01-24
戴纳基盘中异动 快速上涨5.19%报14.40美元
戴纳基盘中异动 下午盘大幅跳水5.01%报14.03美元
市场透视 · 01-17
戴纳基盘中异动 下午盘大幅跳水5.01%报14.03美元
戴纳基盘中异动 快速拉升5.10%
市场透视 · 01-15
戴纳基盘中异动 快速拉升5.10%
加拿大皇家银行:重申Dyne Therapeutics评级
证券之星 · 01-14
加拿大皇家银行:重申Dyne Therapeutics评级
加拿大皇家银行:重申Dyne Therapeutics(DYN.US)评级,由优于大市调整至优于大市评级, 目标价由45.00美元调整至45.00美元。
金融界 · 01-14
加拿大皇家银行:重申Dyne Therapeutics(DYN.US)评级,由优于大市调整至优于大市评级, 目标价由45.00美元调整至45.00美元。
加载更多
公司概况
公司名称:
戴纳基
所属市场:
NASDAQ
上市日期:
--
主营业务:
Dyne Therapeutics, Inc.于2017年12月1日根据特拉华州法律注册成立。该公司正在建立一家领先的肌肉疾病公司,致力于开发针对遗传驱动疾病患者的创新性改变生命的疗法。该公司正在利用其专有的FORCE平台来克服当前肌肉组织输送的局限性,并发展用于肌肉疾病的现代寡核苷酸疗法。
发行价格:
--
{"stockData":{"symbol":"DYN","market":"US","secType":"STK","nameCN":"戴纳基","latestPrice":9.33,"timestamp":1745265600000,"preClose":8.17,"halted":0,"volume":4505997,"hourTrading":{"tag":"盘后","latestPrice":9.33,"preClose":9.33,"latestTime":"19:43 EDT","volume":39183,"amount":365615.6222,"timestamp":1745279008326},"delay":0,"floatShares":97275170,"shares":113121357,"eps":-3.371637,"marketStatus":"已收盘","change":1.16,"latestTime":"04-21 16:00:00 EDT","open":8.17,"high":9.79,"low":8.01,"amount":41600558.393205,"amplitude":0.21787,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.371637,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1600315200000,"exchange":"NASDAQ","adjPreClose":8.17,"preHourTrading":{"tag":"盘前","latestPrice":8.27,"preClose":8.17,"latestTime":"08:24 EDT","volume":16,"amount":134.010016,"timestamp":1745238278333},"postHourTrading":{"tag":"盘后","latestPrice":9.33,"preClose":9.33,"latestTime":"19:43 EDT","volume":39183,"amount":365615.6222,"timestamp":1745279008326},"volumeRatio":2.879867,"impliedVol":1.1834,"impliedVolPercentile":0.876},"requestUrl":"/m/hq/s/DYN","defaultTab":"news","newsList":[{"id":"2527249654","title":"戴纳基盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527249654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527249654?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:55","pubTimestamp":1744811715,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时55分,戴纳基股票出现异动,股价快速下挫5.10%。截至发稿,该股报7.45美元/股,成交量5.5393万股,换手率0.05%,振幅6.37%。机构评级方面,在所有14家参与评级的机构中,93%的券商给予买入建议,7%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为1.23%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621551694d788cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621551694d788cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4505","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2518227151","title":"戴纳基盘中异动 早盘急速下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227151?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:48","pubTimestamp":1741614488,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时48分,戴纳基股票出现异动,股价急速下跌5.24%。截至发稿,该股报11.75美元/股,成交量6.3116万股,换手率0.06%,振幅5.75%。机构评级方面,在所有13家参与评级的机构中,92%的券商给予买入建议,8%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体涨幅为0.26%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214809abf302ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214809abf302ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","DYN","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2517452626","title":"戴纳基2024财年实现净利润-3.17亿美元,同比减少34.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517452626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517452626?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363243,"startTime":"0","endTime":"0","summary":"3月8日,戴纳基公布财报,公告显示公司2024财年净利润为-3.17亿美元,同比减少34.32%;其中营业收入为0.00美元,每股基本收益为-3.37美元。从资产负债表来看,戴纳基总负债61.40百万美元,其中短期债务4.85百万美元,资产负债比为0.12,流动比率为0.16。机构评级:截至2025年3月8日,当前有13家机构对戴纳基目标价做出预测,其中目标均价为48.15美元,其中最低目标价为18.00美元,最高目标价为66.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000127abed6604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000127abed6604&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN"],"gpt_icon":0},{"id":"2516677819","title":"戴纳基盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677819?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:33","pubTimestamp":1741098836,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时33分,戴纳基股票出现异动,股价急速下跌5.03%。截至发稿,该股报11.70美元/股,成交量2.8713万股,换手率0.03%,振幅3.53%。机构评级方面,在所有12家参与评级的机构中,92%的券商给予买入建议,8%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.01%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042233569639453a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042233569639453a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4505","BK4588","DYN"],"gpt_icon":0},{"id":"2514332688","title":"戴纳基盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332688?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:14","pubTimestamp":1740687278,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时14分,戴纳基股票出现异动,股价大幅跳水5.15%。截至发稿,该股报13.08美元/股,成交量119.587万股,换手率1.18%,振幅7.83%。机构评级方面,在所有11家参与评级的机构中,91%的券商给予买入建议,9%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.32%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228041438a256c675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228041438a256c675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","DYN","BK4588"],"gpt_icon":0},{"id":"1167334766","title":"Dyne Therapeutics 2024年第四季度每股收益 $(0.88),优于预期$(0.99)","url":"https://stock-news.laohu8.com/highlight/detail?id=1167334766","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167334766?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:44","pubTimestamp":1740660293,"startTime":"0","endTime":"0","summary":"Dyne Therapeutics 报告称季度每股亏损为$,比分析师一致预期的$高出11.11%。与去年同期每股亏损$相比,这是一个19.27%的改善。以上内容来自Benzinga Earnings专栏,原文如下:Dyne $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.11 percent. This is a 19.27 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DYN"],"gpt_icon":0},{"id":"2510338174","title":"戴纳基盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338174?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:59","pubTimestamp":1739285988,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时59分,戴纳基股票出现波动,股价大幅跳水5.32%。截至发稿,该股报13.71美元/股,成交量7.4737万股,换手率0.07%,振幅3.59%。戴纳基股票所在的生物技术行业中,整体跌幅为1.29%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112259489881c28a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112259489881c28a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","DYN","BK4139","BK4588"],"gpt_icon":0},{"id":"2510898560","title":"戴纳基盘中异动 大幅下跌5.07%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510898560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510898560?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:15","pubTimestamp":1739207744,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时15分,戴纳基股票出现波动,股价大幅下挫5.07%。截至发稿,该股报14.59美元/股,成交量21.8308万股,换手率0.21%,振幅5.47%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-97.13百万美元,每股收益-0.96美元,毛利-400000.00美元,市盈率-4.10倍。戴纳基股票所在的生物技术行业中,整体跌幅为0.22%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211011544961e1fd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211011544961e1fd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4505","DYN","BK4588"],"gpt_icon":0},{"id":"2509082132","title":"戴纳基盘中异动 快速拉升5.17%报16.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509082132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509082132?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:46","pubTimestamp":1738856793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时46分,戴纳基股票出现波动,股价快速拉升5.17%。截至发稿,该股报16.49美元/股,成交量76.7181万股,换手率0.75%,振幅6.86%。戴纳基股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc涨幅较大,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃,换手率分别为5558.48%、1369.62%、135.60%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Azitra Inc、Transcode Therapeutics, Inc.,振幅分别为103.10%、42.43%、39.93%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234633987c9b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234633987c9b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DYN","BK4585","BK4588","BK4505"],"gpt_icon":0},{"id":"2509123145","title":"戴纳基盘中异动 股价大涨5.07%报15.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509123145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509123145?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:23","pubTimestamp":1738776229,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时23分,戴纳基股票出现波动,股价急速上涨5.07%。截至发稿,该股报15.54美元/股,成交量38.5259万股,换手率0.38%,振幅4.90%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-97.13百万美元,每股收益-0.96美元,毛利-400000.00美元,市盈率-4.36倍。戴纳基股票所在的生物技术行业中,整体涨幅为2.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206012349abc3a24a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206012349abc3a24a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","DYN","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2509602204","title":"戴纳基盘中异动 大幅上涨5.19%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509602204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509602204?lang=zh_cn&edition=full","pubTime":"2025-02-05 02:24","pubTimestamp":1738693460,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日02时24分,戴纳基股票出现波动,股价急速上涨5.19%。截至发稿,该股报14.59美元/股,成交量47.6392万股,换手率0.47%,振幅7.07%。戴纳基股票所在的生物技术行业中,整体涨幅为1.36%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1782.21%、971.83%、578.52%,振幅较大的相关个股有Azitra Inc、Cingulate Inc C/Wts 10/12/2026 、Quoin Pharmaceuticals Ltd,振幅分别为72.82%、57.14%、52.61%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205022420a239540c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205022420a239540c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","DYN","BK4139","BK4588"],"gpt_icon":0},{"id":"2508141746","title":"戴纳基盘中异动 早盘大幅下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141746?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:53","pubTimestamp":1738594395,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时53分,戴纳基股票出现波动,股价快速跳水5.03%。截至发稿,该股报13.51美元/股,成交量10.4599万股,换手率0.10%,振幅2.64%。戴纳基股票所在的生物技术行业中,整体跌幅为0.61%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225315987972d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225315987972d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","DYN","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2508962228","title":"戴纳基盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508962228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508962228?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:14","pubTimestamp":1738340092,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时14分,戴纳基股票出现波动,股价快速拉升5.09%。截至发稿,该股报14.86美元/股,成交量110.399万股,换手率1.08%,振幅6.44%。机构评级方面,在所有12家参与评级的机构中,92%的券商给予买入建议,8%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体涨幅为1.38%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201001453abbe4e20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201001453abbe4e20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","DYN","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2507662213","title":"戴纳基盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507662213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507662213?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:44","pubTimestamp":1738248242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时44分,戴纳基股票出现波动,股价急速拉升5.45%。截至发稿,该股报14.28美元/股,成交量5.346万股,换手率0.05%,振幅3.55%。戴纳基股票所在的生物技术行业中,整体跌幅为0.09%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130224402abbd4efc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130224402abbd4efc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","DYN","BK4505","BK4588","BK4139"],"gpt_icon":0},{"id":"2506957648","title":"戴纳基盘中异动 快速上涨5.19%报14.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506957648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506957648?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:24","pubTimestamp":1737739469,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日01时24分,戴纳基股票出现波动,股价急速上涨5.19%。截至发稿,该股报14.40美元/股,成交量197.212万股,换手率1.94%,振幅7.16%。戴纳基股票所在的生物技术行业中,整体涨幅为0.51%。其相关个股中,Evaxion Biotech As、Pmgc Holdings Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为4044.19%、2249.54%、1642.94%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Celularity Inc C/Wts 16/07/2026 ,振幅分别为134.08%、112.09%、69.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125012429960fa9ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125012429960fa9ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","DYN","BK4505","BK4139"],"gpt_icon":0},{"id":"2504511614","title":"戴纳基盘中异动 下午盘大幅跳水5.01%报14.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504511614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504511614?lang=zh_cn&edition=full","pubTime":"2025-01-18 03:59","pubTimestamp":1737143990,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日03时59分,戴纳基股票出现波动,股价急速下跌5.01%。截至发稿,该股报14.03美元/股,成交量121.666万股,换手率1.20%,振幅6.19%。戴纳基股票所在的生物技术行业中,整体涨幅为0.36%。该信息摘要如下:加拿大皇家银行:重申dyne Therapeutics评级,由优于大市调整至优于大市评级,目标价由45.00美元调整至45.00美元。该公司克服了肌肉组织输送和现代寡核苷酸治疗肌肉疾病的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118035951a22602e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118035951a22602e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4505","BK4139","DYN"],"gpt_icon":0},{"id":"2503676624","title":"戴纳基盘中异动 快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503676624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503676624?lang=zh_cn&edition=full","pubTime":"2025-01-16 02:56","pubTimestamp":1736967405,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日02时56分,戴纳基股票出现异动,股价大幅上涨5.10%。截至发稿,该股报15.77美元/股,成交量241.783万股,换手率2.38%,振幅5.50%。戴纳基股票所在的生物技术行业中,整体涨幅为1.20%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。消息层面,截至02时56分,《加拿大皇家银行:重申Dyne Therapeutics评级》资讯为影响戴纳基的重要信息。该公司克服了肌肉组织输送和现代寡核苷酸治疗肌肉疾病的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160256459604ed90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160256459604ed90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","DYN","BK4505","BK4585"],"gpt_icon":0},{"id":"2503509631","title":"加拿大皇家银行:重申Dyne Therapeutics评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2503509631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503509631?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:42","pubTimestamp":1736872965,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:重申dyne Therapeutics(DYN.US)评级,由优于大市调整至优于大市评级,目标价由45.00美元调整至45.00美元。戴纳基(DYN.US)公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。该公司克服了肌肉组织输送和现代寡核苷酸治疗肌肉疾病的局限性。该公司正在开发肌肉疾病的治疗方法,如肌强直性营养不良症、杜氏肌营养不良症和面肩肱肌营养不良症。该公司的候选产品是DYNE-101和DYNE-251,均处于正在进行的1/2期临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115004500a221d588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115004500a221d588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","LENZ"],"gpt_icon":0},{"id":"2503505804","title":"加拿大皇家银行:重申Dyne Therapeutics(DYN.US)评级,由优于大市调整至优于大市评级, 目标价由45.00美元调整至45.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503505804","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503505804?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:32","pubTimestamp":1736872326,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:重申Dyne Therapeutics(DYN.US)评级,由优于大市调整至优于大市评级, 目标价由45.00美元调整至45.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15003247459014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DYN","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dyne-tx.com","stockEarnings":[{"period":"1week","weight":0.1705},{"period":"1month","weight":-0.3506},{"period":"3month","weight":-0.4218},{"period":"6month","weight":-0.7682},{"period":"1year","weight":-0.6708},{"period":"ytd","weight":-0.6532}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dyne Therapeutics, Inc.于2017年12月1日根据特拉华州法律注册成立。该公司正在建立一家领先的肌肉疾病公司,致力于开发针对遗传驱动疾病患者的创新性改变生命的疗法。该公司正在利用其专有的FORCE平台来克服当前肌肉组织输送的局限性,并发展用于肌肉疾病的现代寡核苷酸疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.003365},{"month":2,"riseRate":0.4,"avgChangeRate":0.04136},{"month":3,"riseRate":0.4,"avgChangeRate":-0.063194},{"month":4,"riseRate":0.2,"avgChangeRate":-0.066617},{"month":5,"riseRate":0.5,"avgChangeRate":0.022774},{"month":6,"riseRate":0.75,"avgChangeRate":0.124906},{"month":7,"riseRate":0.75,"avgChangeRate":0.17109},{"month":8,"riseRate":0.25,"avgChangeRate":-0.029699},{"month":9,"riseRate":0.25,"avgChangeRate":-0.044882},{"month":10,"riseRate":0.2,"avgChangeRate":-0.118868},{"month":11,"riseRate":0.6,"avgChangeRate":0.122553},{"month":12,"riseRate":0.4,"avgChangeRate":-0.032191}],"exchange":"NASDAQ","name":"戴纳基","nameEN":"Dyne Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"戴纳基,DYN,戴纳基股票,戴纳基股票老虎,戴纳基股票老虎国际,戴纳基行情,戴纳基股票行情,戴纳基股价,戴纳基股市,戴纳基股票价格,戴纳基股票交易,戴纳基股票购买,戴纳基股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}